Temerty researcher receives grant for AI for diabetes prediction and prevention
Toronto, ON – September 14, 2023 – Jay Shaw, an assistant professor in the department of physical therapy at the Temerty Faculty of Medicine at the University of Toronto, has received a grant of more than $900,000 from the Canadian Institute for Advanced Research (CIFAR) to develop a novel framework for using machine learning models to predict diabetes risk.
The grant is part of CIFAR's Transformative AI program, which supports research that has the potential to significantly advance the field of artificial intelligence. Shaw's project will focus on developing a framework that can use data from a variety of sources, such as electronic health records, wearable devices, and surveys, to identify people who are at high risk of developing diabetes.
MIRHA
"This grant is a major step forward in our work to develop new ways to prevent and manage diabetes," said Shaw. "By using AI, we can identify people who are at risk of developing the disease early on, and intervene to prevent it from happening."
MIRHA
Diabetes is a chronic condition that affects millions of people around the world. It is characterized by high blood sugar levels, which can lead to a number of health problems, including heart disease, stroke, and blindness.
MIRHA
Shaw's project is one of a number of research initiatives that are using AI to improve the prevention and management of diabetes. Other projects are using AI to develop new treatments for the disease, to personalize diabetes care, and to improve the accuracy of diabetes self-management.
MI
"AI has the potential to revolutionize the way we prevent and manage diabetes," said Shaw. "This grant will allow us to take a major step forward in this important work."
<p data-sourcepos="17:1-17:189" style="background-color: white; color: #1f1f1f; font-family: "Google Sans", "Helvetica Neue", sans-serif; font-size: 16px; margin: 24px 0px; white-space-collapse: preserve; word-break: break-word;">The project is expected to take three years to complete. Shaw is co-leading the project with Dr. Michael A. Schwartz, a professor in the department of medicine at the University of Toronto.<div class="separator" style="clear: both; text-align: cent

Comments
Post a Comment